plicamycin has been researched along with Hepatocellular Carcinoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, Z; Li, M; Shen, H; Tang, Y; Wang, D; Yang, J | 1 |
| Aranda, E; Corrales, FJ; López-Pedrera, C; López-Sánchez, LM; Rodríguez-Ariza, A | 1 |
| Kardassis, D; Koutsodontis, G | 1 |
3 other study(ies) available for plicamycin and Hepatocellular Carcinoma
| Article | Year |
|---|---|
Iron Deficiency Increases Phosphorylation of SP1 to Upregulate SPNS2 Expression in Hepatocellular Carcinoma.
Topics: Anion Transport Proteins; Carcinoma, Hepatocellular; Humans; Iron Deficiencies; Liver Neoplasms; Phosphorylation; RNA, Messenger; Sp1 Transcription Factor; Transcription Factors | 2023 |
Pharmacological impairment of s-nitrosoglutathione or thioredoxin reductases augments protein S-Nitrosation in human hepatocarcinoma cells.
Topics: Antirheumatic Agents; Auranofin; Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Nitrosation; Plicamycin; Proteins; Proteomics; S-Nitrosoglutathione; Spectrometry, Mass, Electrospray Ionization; Thioredoxin-Disulfide Reductase; Tumor Cells, Cultured | 2010 |
Inhibition of p53-mediated transcriptional responses by mithramycin A.
Topics: Base Sequence; Binding Sites; Carcinoma, Hepatocellular; Cell Cycle Proteins; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p21; DNA Damage; DNA Primers; Humans; Liver Neoplasms; Plicamycin; Promoter Regions, Genetic; Reverse Transcriptase Polymerase Chain Reaction; Sp1 Transcription Factor; Transcription, Genetic; Tumor Suppressor Protein p53 | 2004 |